Clinical Trial Update: Maintenance Study on the Long Term Safety of XL999 [Phase 1]

View source ↗

Summary

A Phase 1 maintenance study evaluating the long-term safety of XL999 in patients with advanced cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• XL999

Snippet

Sponsor: Symphony Evolution, Inc. | Conditions: Advanced Malignancies | Phase 1 | Status: COMPLETED